Original title: Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Reference: Reinecke H et al. Eur Heart J. 2015; Epub ahead of print. This work included 41882 patients retrospectively from health insurance in Germany admitted with diagnosis of peripheral vascular disease between 2009 and 2011 and followed until 2013. Patients<a href="https://solaci.org/en/2015/02/20/n-5006/" title="Read more" >...</a>
Impact of kidney function on TAVI outcome
Original title: Impact of chronic kidney disease on the outcome of transcatheter aortic valve implantation: results from the FRANCE 2 Registry. Reference: Atsushi Oguri, et al. EuroIntervention 2015;10:e1-9 Globally, 13% of patients present kidney failure, which has been associated to a worse evolution not only of TAVI outcomes but also of other cardiovascular intervention outcomes. Most studies, including<a href="https://solaci.org/en/2015/02/19/n-4999/" title="Read more" >...</a>
Greater platelet reactivity in diabetic patients receiving DES and clopidogrel
Original title: Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement. Reference: Feldman L. et al. Am Heart J. 2014; Epub ahead of print. Diabetes mellitus type 2 (T2DM) or metabolic syndrome patients undergoing drug eluting stent implantation have 3 to 4<a href="https://solaci.org/en/2014/10/20/n-4761/" title="Read more" >...</a>
Thrombosis with bioresorbable scaffolds: the story of DES all over again?
Original title: Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. Reference: Capodanno D et al. EuroIntervention. 2014 Jul 18. Epub ahead of print The GHOST-EU registry, that included 1189 patients from 10 European centers between 2011 and 2014, is now the largest registry<a href="https://solaci.org/en/2014/07/30/n-4628/" title="Read more" >...</a>
Transcatheter Aortic Valve Replacement showed better results than conventional surgery in high risk diabetic patients.
Original title: Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery An Analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). Reference: Lindman BR et al. J Am Coll Cardiol. 2014 Mar 25;63(11):1090-9. Diabetes is associated to greater morbidity and mortality after surgical aortic valve replacement (SAVR),<a href="https://solaci.org/en/2014/03/26/n-4369/" title="Read more" >...</a>
The complete Left Bundle Branch Block after TAVI is not associated with increased mortality at 12 months
Original title: Impact of New-Onset Persistent Left Bundle Branch Block on late Clinical Outcomes in Patients Undergoing Trancatheter Aortic Valve implantation with a Balloon –Expandable Valve. Reference: Urena Marina, el al. JACC Cardiovasc Interv. 2014 Feb;7(2):128-36. Percutaneous aortic valve implantation brings, sometimes the presence of permanent left bundle branch block (LBBB) that has been associated in some series<a href="https://solaci.org/en/2014/03/18/n-4348/" title="Read more" >...</a>
Ischemic versus anatomical risk. Is anyone better to help us decide therapeutically?
Original title: Predicting Outcome in the COURAGE Trial. Coronary Anatomy Versus Ischemia. Reference: G. B. John Mancini et al. J Am Coll Cardiol Intv 2013, Article in press. Anatomical risk, ischemic amount or a combination of both, are often factors taken into account for estimating the prognosis or choose a treatment strategy. The COURAGE study (Clinical Outcomes Utilizing<a href="https://solaci.org/en/2014/01/24/n-4180/" title="Read more" >...</a>
Unprotected trunk in diabetics: angioplasty with good long-term results but more revascularization
Original title: Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: D-DELTA registry. Reference: Meliga Emanuele, et al. EuroIntervention 2013; 9:803-808 Diabetes increases cardiovascular risk events because of their involvement in diffuse form of the vessels, thereby generating more events and changes in revascularization strategy<a href="https://solaci.org/en/2013/12/12/n-4152/" title="Read more" >...</a>
Infrapatellar balloon angioplasty, the easiest option and with better results in critical ischemia with tissue loss
Original title: Longitudinal outcomes After Tibioperoneal Angioplasty Alone Compared to Tibial Stenting and Atherectomy for Critical Limb ischemia. Reference: Shaun Reynolds et al. Vascular and and Endovascular Surgery 2013 47(7):507-512 The Infrapatellar peripheral vascular disease has increased in recent years, relating to tissue loss and amputation. The therapeutic strategy is not clear, let alone the use of stents<a href="https://solaci.org/en/2013/11/21/n-4089/" title="Read more" >...</a>
Clinical factors to help decide between angioplasty and carotid endarterectomy
Original title: A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy: Systematic review of observational studies with validation in randomized trials. Reference: Touzé E et al. Stroke. 2013;Epub ahead of print Compared with carotid endarterectomy, angioplasty with stent is associated with an increased risk of pre- procedural stroke especially for<a href="https://solaci.org/en/2013/11/12/n-4068/" title="Read more" >...</a>